We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+10.33%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$70.7B
AUM Growth
+$2.25B
Cap. Flow
-$3.76B
Cap. Flow %
-5.32%
Top 10 Hldgs %
10.84%
Holding
2,524
New
171
Increased
580
Reduced
1,478
Closed
87

Top Sells

Rank Stock Value
1
ALL icon
Allstate
ALL
+$693M
2
INTC icon
Intel
INTC
+$664M
3
T icon
AT&T
T
+$547M
4
PARA
Paramount Global Class B
PARA
+$295M
5
DIS icon
Walt Disney
DIS
+$173M

Sector Composition

Rank Sector Weight
1 Technology 17.73%
2 Healthcare 15.12%
3 Financials 14.74%
4 Industrials 12.02%
5 Consumer Discretionary 9.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IVR icon
2326
Invesco Mortgage Capital
IVR
$776M
$11K ﹤0.01%
265
-204
-43% -$7.7K
RCEL icon
2327
Avita Medical
RCEL
$142M
$11K ﹤0.01%
576
-8,305
-94% -$193K
RDNT icon
2328
RadNet
RDNT
$4.84B
$11K ﹤0.01%
516
-245
-32% -$4.96K
TVRD
2329
Tvardi Therapeutics
TVRD
$23.5M
$11K ﹤0.01%
14
-7
-33% -$4.79K
SDC
2330
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
$11K ﹤0.01%
1,100
-3,421
-76% -$40.5K
NTUS
2331
DELISTED
Natus Medical Inc
NTUS
$11K ﹤0.01%
425
-201
-32% -$5.15K
AGM icon
2332
Federal Agricultural Mortgage
AGM
$2.27B
$10K ﹤0.01%
100
-48
-32% -$4.14K
CVM icon
2333
CEL-SCI Corp
CVM
$20.6M
$10K ﹤0.01%
23
-11
-32% -$6.01K
KIDS icon
2334
OrthoPediatrics
KIDS
$485M
$10K ﹤0.01%
208
-98
-32% -$4.7K
OMER icon
2335
Omeros
OMER
$709M
$10K ﹤0.01%
574
-272
-32% -$5.29K
OSUR icon
2336
OraSure Technologies
OSUR
$273M
$10K ﹤0.01%
828
-392
-32% -$4.8K
RYTM icon
2337
Rhythm Pharmaceuticals
RYTM
$7B
$10K ﹤0.01%
467
-222
-32% -$6.44K
SPNT icon
2338
SiriusPoint
SPNT
$2.98B
$10K ﹤0.01%
982
-466
-32% -$4.73K
XENE icon
2339
Xenon Pharmaceuticals
XENE
$6.32B
$10K ﹤0.01%
539
-256
-32% -$4.34K
TECX
2340
Tectonic Therapeutic
TECX
$573M
$10K ﹤0.01%
67
-21
-24% -$3.42K
ATHX
2341
DELISTED
Athersys, Inc. Common Stock
ATHX
$10K ﹤0.01%
223
-68
-23% -$3.53K
ANAT
2342
DELISTED
American National Group, Inc. Common Stock
ANAT
$10K ﹤0.01%
90
-43
-32% -$4.19K
AGEN
2343
Agenus
AGEN
$249M
$9K ﹤0.01%
167
-51
-23% -$3.69K
OSG
2344
Octave Specialty Group
OSG
$252M
$9K ﹤0.01%
514
-243
-32% -$3.97K
DEO icon
2345
Diageo
DEO
$46.2B
$9K ﹤0.01%
56
+4
+8% +$654
GERN icon
2346
Geron
GERN
$911M
$9K ﹤0.01%
5,935
-2,814
-32% -$5.03K
LAB icon
2347
Standard BioTools
LAB
$326M
$9K ﹤0.01%
+1,933
New +$10.6K
MBWM icon
2348
Mercantile Bank Corp
MBWM
$1.01B
$9K ﹤0.01%
288
-137
-32% -$4.13K
SIGA icon
2349
SIGA Technologies
SIGA
$223M
$9K ﹤0.01%
+1,355
New +$9.19K
TBBK icon
2350
The Bancorp
TBBK
$2.79B
$9K ﹤0.01%
440
-208
-32% -$4.04K

Similar funds

Macquarie Group's Q1 2021 Portfolio in Review

As of Q1 2021, Macquarie Group held 2,524 positions worth $70.7B, up 3.3% from $68.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Macquarie Group withdrew a net $3.76B in Q1 2021, closing 87 positions and reducing 1,478 holdings. Its most notable exit was iShares Core S&P Total US Stock Market ETF, an estimated $140M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Macquarie Group opened a new position in Sunrun worth $77.7M.

  • Macquarie Group's largest Q1 2021 buy was Sunrun: 1,285,424 shares worth $77.7M.
  • Macquarie Group added most to MetLife in Q1 2021, an estimated $627M increase.
  • Macquarie Group's biggest Q1 2021 reduction was Allstate, cutting an estimated $693M.
  • Macquarie Group fully exited iShares Core S&P Total US Stock Market ETF in Q1 2021, selling an estimated $140M.
  • Macquarie Group's ten largest holdings make up 11% of its $70.7B portfolio in Q1 2021.
  • Macquarie Group opened 171 new positions and closed 87 in Q1 2021.
  • Macquarie Group's portfolio value rose 3.3% quarter-over-quarter to $70.7B.

Based on Macquarie Group's 13F filing for Q1 2021, filed 14 May 2021.